• Home
  • Search Results

Search Results

448 studies match your search
Open

Registry for Adults With Plasma Cell Disorders.

Have you been diagnosed with a plasma cell disorder? You may be able to join a registry to help us learn more about the effects of plasma cell disorders on different aspects of life.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Multiple Myeloma)
Open

Ulixertinib/Palbociclib in Patients With Advanced Melanoma

Have you been diagnosed with melanoma? If so, you may be eligible to take part in a research study looking at the safety of giving a combination of drugs called Ulixertinib and Palbociclib to patients with advanced melanoma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Melanoma)

CD19 CAR T-cells containing a Safety Switch to treat Relapsed /Refractoy Acute Lymphoblastic Leukemia

The purpose of this study is to establish a safe dose of study cells to give to patients with relapsed/ refractory ALL expressing CD19.

Age & Gender
  • 3 years ~ 70 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

CD30 CAR-T cells for Hodgkin's/Non-Hodgkin's Lymphom

Do you have lymphoma that has come back, or did not get better with the last treatment you were given? If so, you might able to participate in a study to see if the study team can make modified T cells that are able to fight and kill the lymphoma cells.

Age & Gender
  • 3 years ~ 17 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Visit Location
Open

Collection of Tissue, Blood, Urine, Hair, and Saliva for Research Related to Patients with Genitourinary Malignancies

Do you have bladder, kidney, prostate, or another genitourinary cancer diagnosis? If so, you may be able to take part in a research study collecting specimens (e.g., blood, urine, saliva, tissue) during your already scheduled appointments. Collecting these specimens may help researchers develop new ways to detect cancer earlier or to more effectively treat cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Kidney, Prostate)
By physician referral or invitation only

NMDP Research Sample Repository

The primary objective of this repository is to make blood samples available for research studies related to histocompatibility and HC transplantation or other cellular therapy.

Age & Gender
  • 7 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pediatric Cancers, Leukemia, Lymphoma, Multiple Myeloma)
  • Transplant
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Dynamics of Aging and Cognitive Function

We will collect one more round of data from participants >= 45 years and analyze factors associated with aging and cognitive function.

Age & Gender
  • 45 years ~ 99 years
  • Male, Female
Study Interest
  • Aging
  • Blood Conditions
  • Cancer (Breast, Liver, Lung, Stomach and Esophageal)
  • and 15 more
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Adaptation of a Patient Navigation Program Study

This study seeks to better understand the unmet needs and care preferences of young adult cancer patients and their caregivers. Interviews to gather this information will be used to tailor an existing, evidence-based patient navigation program to these needs and preferences.

Age & Gender
  • 18 years ~ 50 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Brain and Other Nervous System, Breast, and 18 more)
  • Opinions and Perceptions
  • UNC or UNC Health employees
  • and 2 more
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

ARAR2331: Prospective Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB)

Pleuropulmonary Blastoma (PPB) is a rare lung tumor in young children that can grow in stages from less serious (Type I) to more dangerous (Type III). This study will test how well a drug combo: vincristine, topotecan, and cyclophosphamide (VTC) works for serious types (Type II and III) and help decide which patients with less serious tumors (Type I and Type Ir (regressed) PPB ) need chemotherapy after surgery. Researchers will also study the biology of the tumor to learn more about it.

Age & Gender
  • 0 years ~ 21 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung, Pediatric Cancers)
  • Rare Diseases
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Let's Talk: Lynch Syndrome Screening Study

The main goal of this project is to create an interactive online version of the Let's Talk program and test it with patients who have Lynch syndrome to see if it works well in a medical setting.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Cancer (Colorectal, Uterine (endometrial))
  • Genetics and Genetic Disorders
  • UNC or UNC Health employees
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research